2016-09-15 12:17:15 UTC
Sept. 15, 2016
On-demand recording: Dr. David T. Rubin discusses current and future biomarkers for IBD, and also new tools that could help IBD patients.
Select presentations from the 2016 AGA Tech Summit are now available in the Education section of the AGA website. One you won’t want to miss: David T. Rubin, MD, AGAF, discussing future biomarkers to assess IBD disease activity. During his presentation, he provides a framework for biomarkers in IBD, discussing:
- Currently available biomarkers in IBD.
- New tools of interest for IBD patients.
- The utility of serologies and genetic markers.
- Future directions in therapeutic drug monitoring.